BiotechTube
Home/Vesper Bio/Andy Mulvaney
AM

Andy Mulvaney

Business Development Consultant

Vesper Bio

Therapeutic Areas

NeurologyOphthalmology

Vesper Bio Pipeline

DrugIndicationPhase
VES001Frontotemporal Degeneration (FTD-GRN)Phase 2
Sortilin Inhibitor ProgramParkinson's DiseasePreclinical

Leadership Team at Vesper Bio

AN
Anders Nykjær
Founder
GW
Graham Wynne
Medicinal Chemistry Consultant
JK
John King-Underwood
Medicinal Chemistry Consultant
View full Vesper Bio profile